This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Johns Hopkins University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Jefferson J Doyle: Innovator in Marfan Syndrome Treatment
Introduction
Jefferson J Doyle is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of medical research, particularly in the treatment of Marfan syndrome. His innovative work has led to the development of methods and compositions that aim to improve the diagnosis, treatment, and prevention of this complex condition.
Latest Patents
Doyle holds a patent titled "Map kinase pathway targets for the treatment of Marfan syndrome." This patent provides essential methods and compositions for diagnosing, treating, and preventing Marfan syndrome and related diseases, disorders, and conditions. The disclosure also includes pharmaceutical compositions and kits designed for these purposes, showcasing his commitment to advancing medical science.
Career Highlights
Jefferson J Doyle is affiliated with Johns Hopkins University, a prestigious institution known for its research and innovation in various fields. His work at the university has allowed him to focus on groundbreaking research that addresses critical health issues, particularly those affecting individuals with Marfan syndrome.
Collaborations
Doyle has collaborated with esteemed colleagues, including Harry C Dietz and Alexander J Doyle. These partnerships have fostered a collaborative environment that enhances the research and development of effective treatments for Marfan syndrome.
Conclusion
Jefferson J Doyle's contributions to the field of medical research, particularly in the treatment of Marfan syndrome, highlight his innovative spirit and dedication to improving patient outcomes. His work continues to inspire advancements in medical science and offers hope to those affected by this condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
